One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study
SECTIONS
Last Updated: Apr 28, 2021, 03:34 PM IST
Share
Synopsis
The researchers from King s College London in the UK also found that most systemic side effects meaning side effects excluding where the injection took place peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
PTI
People wait after being vaccinated with Covishield vaccine at a government health care centre in New Delhi.
3,131,660.0
One in four people experience mild, short lived systemic side effects after receiving either the COVID-19 preventive by Pfizer or AstraZeneca vaccine known as Covishield in India with headache, fatigue and tenderness the most common symptoms, according to a study published in the Lancet Infectious Diseases journal. The researchers from King s College London in the UK also found that most systemic side effects meaning side effects excluding where the
One in four people experience mild side effects from Covishield Covid-19 vaccine: Lancet study | India News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.